Loading
SM
Sequana Medical Stock: price and insider trades · Belgium
ISIN BE0974340722BE·
No insider purchase over the last 90 days. The latest was filed 04 Jun 2026.
Sequana Medical: what insiders have been doing
Sequana Medical, founded in 2018, is a listed company based in Ghent, Belgium. Its directors and officers file their transactions with FSMA. Between 18 October 2025 and 18 October 2026, 1 insider published 1 filing.
Only purchases show up on the open market, 1 purchase in all worth €2,570, filed by 1 insider. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €2,570, bought by Chauvineau Pierre and made public on 4 June 2026. Among those who bought: 1 board member.
The latest purchase dates back some time: it was published 136 days ago, on 4 June 2026.
For context, the typical company on the same exchange (median of 77 companies) published 11 filings over the same period, against 1 filing here. Our records for Sequana Medical go back to 2021, with 10 purchases and no sales on the open market in total.
Source: insider filings from FSMA. Past trades are no guide to future returns.
Key facts
Headquarters: Ghent, Belgium · Founded: 2018
Source: Wikidata (CC0).
Insider Decl.
10
Thresholds
n/a
Buy Volume
€81,682
10 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 4 June 2026
Declarations10 total
23,364 shares@ €0.114.8% of flowShareEuronext BrusselsISIN BE0974340722FSMA:sequana-medical-9
Canonical exit: 3 Oct 2024 (T+90)
12,755 shares@ €0.1117.8% of flowShareEuronext BrusselsISIN BE0974340722FSMA:sequana-medical-4
Canonical exit: 2 Jan 2024 (T+90)
12,755 shares@ €0.11100.0% of flowShareEuronext BrusselsISIN BE0974340722FSMA:sequana-medical-5
Canonical exit: 2 Jan 2024 (T+90)
12,755 shares@ €0.112.8% of flowShareEuronext BrusselsISIN BE0974340722FSMA:sequana-medical-1
Canonical exit: 2 Jan 2024 (T+90)
12,755 shares@ €0.11100.0% of flowShareEuronext BrusselsISIN BE0974340722FSMA:sequana-medical-3
Canonical exit: 2 Jan 2024 (T+90)
2,000 shares@ €3.2582.2% of flowShareEuronext BrusselsISIN BE0974340722FSMA:sequana-medical-8
Canonical exit: 26 Jul 2023 (T+90)
5,000 shares@ €3.50100.0% of flowShareEuronext BrusselsISIN BE0974340722FSMA:sequana-medical-6
Canonical exit: 27 Jul 2023 (T+90)
7,664 shares@ €6.4697.2% of flowShareEuronext BrusselsISIN BE0974340722FSMA:sequana-medical
Canonical exit: 8 Dec 2021 (T+90)
32,000 shares0Options /warrants for employees or managersEuronext BrusselsISIN BE0974340722FSMA:sequana-medical-2
Canonical exit: 25 Aug 2021 (T+90)
10 of 10 declarations
About Sequana Medical
SEQUANA MEDICAL is a company focused on developing innovative solutions for the treatment of ascites and other diseases related to fluid accumulation. It is listed on the XBRU market.
